Divalproex Sodium
Product Images NDC 16590-648

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 16590-648). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sod Dr 500mg Label Image (Divalproex Sod Dr 500mg Label)

FDA Label Image

Divalproex-na-fig1 (Divalproex Na Fig1)

The text provided is a comparison between two studies, "Study 1" and "Study 2", using two different measures denoted by "YMRS" and "MRS". There is evidence of statistical significance denoted by "*p<0.05" for the comparison of the treatments "PBO" (placebo) to "DVPX" (divalproex sodium delayed-release tablets). No further information is available.*

FDA Label Image

Divalproex-na-fig2 (Divalproex Na Fig2)

This text describes two studies involving the use of divalproex sodium delayed-release tablets, also referred to as DVPX. In Study 1 and Study 2, the mean dose of the medication was 1087 mg/day. In Study 2, the doses ranged from 500 to 1000 mg/day. This information may be helpful for healthcare professionals when determining dosages for patients receiving this medication.*

FDA Label Image

Divalproex-na-fig3 (Divalproex Na Fig3)

FDA Label Image

Divalproex-na-fig4 (Divalproex Na Fig4)

FDA Label Image

Divalproex-na-structure (Divalproex Na Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.